JF
Jeff Fecho
VP, Global Quality

Jeff Fecho insider trades: St Jude Medical (STJ) stock sales

VP, Global Quality, St Jude Medical Last trade Feb 5, 2016 31 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2012
2
Companies
last trade 2016

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jeff reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 5, 2016STJ↓ Sell$538K
Oct 26, 2015STJ↓ Sell$47K
May 1, 2015STJ↓ Sell$370K
Jan 30, 2015STJ↓ Sell$615K
Oct 27, 2014STJ↓ Sell$30K
Jul 18, 2014STJ↓ Sell$474K
Jan 27, 2014STJ↓ Sell$638K
Jul 19, 2013STJ↓ Sell$704K
Jan 25, 2013STJ↓ Sell$283K
Nov 1, 2012STJ↓ Sell$3K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jeff Fecho's insider trades

Jeff Fecho is VP, Global Quality at St Jude Medical (STJ). Since Nov 1, 2012, Jeff has reported no open-market purchases and 10 sales worth $3.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (18 filings), shares withheld for taxes (12 filings), grants and awards (10 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every STJ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.